Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2008-02-15
Original market date: See footnote 1
1996-09-10
Product name:
M.T.E.-6 CONCENTRATED
DIN:
02139235
Product Monograph/Veterinary Labelling:
Date:
2008-01-15
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
PHARMACEUTICAL PARTNERS OF CANADA INC
45 Vogell Road, Suite 200
Richmond Hill
Ontario
Canada
L4B 3P6
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
6
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
40:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
B05XA30 COMBINATIONS OF ELECTROLYTES
Active ingredient group (AIG) number:See footnote5
0623891001
| Active ingredient(s) | Strength |
|---|---|
| CHROMIUM (CHROMIC CHLORIDE) | 10 MCG / ML |
| COPPER (CUPRIC SULFATE) | 1 MG / ML |
| IODIDE (SODIUM IODIDE) | 75 MCG / ML |
| MANGANESE (MANGANESE SULFATE) | 0.5 MG / ML |
| SELENIUM (SELENIOUS ACID) | 60 MCG / ML |
| ZINC (ZINC SULFATE) | 5 MG / ML |